Phase II trial of two different irinotecan schedules with pharmacokinetic analysis in patients with recurrent glioma: North Central Cancer Treatment Group results
Year: 2008
Type: article
Study design: Clinical Trial
Source: Journal of Neuro-Oncology
Institutions: Mayo Clinic, Universidad de Navarra, Mayo Clinic in Florida
Language: English
Subfield: Genetics
Field: Medicine
Domain: Health Sciences
Open Access status: green
Funder: National Cancer Institute
Awards: G1094409381, G1423238671, G1539327064, G179864828, Sanford Community Cancer Consortium, G2082142344, G2383270398, G2440672419, G248987615, Geisinger Clinical Oncology Program, MICHIGAN CANCER RESEARCH CONSORTIUM CCOP, Sanford Community Cancer Program of the North Central Plains (NCORP), G358241105, G3789417232, TOLEDO COMMUNITY CLINICAL ONCOLOGY PROGRAM, North Central Cancer Treatment Group, Cedar Rapids Oncology Project, Carle Cancer Center Community Clinical Oncology Program, Missouri Valley Cancer Consortium CCOP, Duluth Community Clinical Oncology Program, Sanford Community Cancer Consortium, Iowa Oncology Research Association, G937543590
OpenAlex ID: W2094943043